1064 related articles for article (PubMed ID: 19596491)
1. Extended-spectrum beta-lactamase-producing organisms.
Falagas ME; Karageorgopoulos DE
J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of extended-spectrum beta-lactamases.
Rodríguez-Baño J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum beta-lactamases.
Turner PJ
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S273-5. PubMed ID: 16032564
[TBL] [Abstract][Full Text] [Related]
5. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
6. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
[TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
Yu WL; Chuang YC; Walther-Rasmussen J
J Microbiol Immunol Infect; 2006 Aug; 39(4):264-77. PubMed ID: 16926972
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
Harada S; Ishii Y; Yamaguchi K
Korean J Lab Med; 2008 Dec; 28(6):401-12. PubMed ID: 19127103
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamases. An overview.
Patterson JE
Postgrad Med; 2001 Feb; 109(2 Suppl):32-8. PubMed ID: 19667555
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
12. Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.
Fihman V; Lartigue MF; Jacquier H; Meunier F; Schnepf N; Raskine L; Riahi J; Sanson-le Pors MJ; Berçot B
J Infect; 2008 Jun; 56(6):454-9. PubMed ID: 18440645
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538
[TBL] [Abstract][Full Text] [Related]
14. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists.
Colodner R
Am J Infect Control; 2005 Mar; 33(2):104-7. PubMed ID: 15761410
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
[TBL] [Abstract][Full Text] [Related]
18. Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Italy.
Perilli M; Segatore B; Mugnaioli C; Celenza G; Rossolini GM; Stefani S; Luzzaro F; Pini B; Amicosante G
Microb Drug Resist; 2011 Dec; 17(4):521-4. PubMed ID: 21970626
[TBL] [Abstract][Full Text] [Related]
19. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
Sante; 1999; 9(6):341-4. PubMed ID: 10705312
[TBL] [Abstract][Full Text] [Related]
20. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
